Browse COVID-19 resources from partners and CCSA experts – trusted sources for your information and research needs.

Canadian Centre on Substance Use and Addiction

The information on COVID-19 and substance use in this section comes from resource collections, academic publications, policies and guides from the federal, provincial and territorial governments as well as professional organizations.

CCSA cannot vouch for the accuracy or currency of the information in these resources. Inclusion of a resource on this page does not imply endorsement or authorization by CCSA.

Academic Publications

Academic Publications

Resource Organization
Mitigating and learning from the impact of COVID‐19 infection on addictive disorders Addiction
Rapid Implementation of Service Delivery Changes to Mitigate COVID-19 and Maintain Access to Methadone Among Persons with and at High-Risk for HIV in an Opioid Treatment Program AIDS and Behavior
Are Patients With Alcohol Use Disorders at Increased Risk for Covid-19 Infection? Alcohol and Alcoholism
Complicated Alcohol Withdrawal—An Unintended Consequence of COVID-19 Lockdown Alcohol and Alcoholism
Editorial: Challenges to Opioid Use Disorders During COVID-19 American Journal of Addictions
Caring for patients with pain during the COVID-19 pandemic: consensus recommendations from an international expert panel Anaesthesia
Collision of the COVID-19 and Addiction Epidemics Annals of Internal Medicine
An Epidemic in the Midst of a Pandemic: Opioid Use Disorder and COVID-19 Annals of Internal Medicine
When Epidemics Collide: Coronavirus Disease 2019 (COVID-19) and the Opioid Crisis Annals of Internal Medicine
COVID-19 pandemic and addiction: Current problems and future concerns Asian Journal of Psychiatry
Association of the Covid-19 lockdown with smoking, drinking, and attempts to quit in England: an analysis of 2019-2020 data BMJ
Don't forget our dual public health crises Canadian Journal of Emergency Medicine
Is another public health crisis brewing beneath the COVID-19 pandemic? Canadian Journal of Public Health
Cannabinoids and the Coronavirus Cannabis and Cannabinoid Research
People Who Use Drugs Are Experiencing Overlapping Crises During COVID-19 CMAJ
COVID-19 and addiction Diabetes & Metabolic Syndrome: Clinical Research & Reviews
Overdose and risk factors for coronavirus disease 2019 Drug and Alcohol Dependence
Illicit drug use and harms in Australia in the context of COVID ‐19 and associated restrictions: Anticipated consequences and initial response Drug and Alcohol Review
Alcohol use in times of the COVID 19: Implications for monitoring and policy Drug and Alcohol Review
Challenges of methadone maintenance treatment during the COVID-19 epidemic in China: policy and service recommendation European Neuropsychopharmacology
Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic Harm Reduction Journal
An urgent impetus for action: safe inhalation interventions to reduce COVID-19 transmission and fatality risk among people who smoke crack cocaine in the United Kingdom International Journal on Drug Policy
Cannabis in the Time of Coronavirus Disease 2019: The Yin and Yang of the Endocannabinoid System in Immunocompetence The Journal of Alternative and Complementary Medicine
COVID‐19 During the Opioid Epidemic – Exacerbation of Stigma and Vulnerabilities Journal of Rural Health
A Primary Care Response to COVID‐19 for Patients with an Opioid Use Disorder Journal of Rural Health
Public health messaging and harm reduction in the time of COVID-19 The Lancet
COVID-19 Resource Centre  The Lancet
Alcohol use and misuse during the COVID-19 pandemic: a potential public health crisis? The Lancet
Drinking alone: COVID-19, lockdown, and alcohol-related harm The Lancet Gastroenterology & Hepatology
Innovative strategies to support physical distancing among individuals with active addiction The Lancet, Psychiatry
Alcohol use and misuse during the COVID-19 pandemic: a potential public health crisis? The Lancet, Public Health
Avoiding a new epidemic during a pandemic: The importance of assessing the risk of substance use disorders in the COVID-19 era Psychiatry Research
COVID19 pandemic and people with opioid use disorder: innovation to reduce risk Psychiatry Research
How is the COVID-19 pandemic changing our use of illegal drugs? An overview of ongoing research Society for the Study of Addiction
Canadians report lower self-perceived mental health during the COVID-19 pandemic Statistics Canada
Opioid use disorder and the COVID 19 pandemic: A call to sustain regulatory easements and further expand access to treatment Substance Abuse

 

Federal, Provincial and Territorial Policies and Guides

Federal, Provincial and Territorial Policies and Guides

Resource Organization
CDSA Exemption and Interpretive Guide for Controlled Substances Health Canada
Exceptional importation & sale of drugs in relation to COVID-19: Tier 3 drug shortages Health Canada
Frequently Asked Questions: Subsection 56(1) Class Exemption for Patients, Practitioners and Pharmacists Prescribing and Providing Controlled Substances in Canada during the Coronavirus Pandemic Health Canada
Provincial/Territorial Class Exemptions for Supervised Consumption Site Operators Health Canada
Subsection 56(1) class exemption for patients, practitioners and pharmacists prescribing and providing controlled substances in Canada during the coronavirus pandemic Health Canada
In the time of COVID-19: Civil society statement on COVID-19 and people who use drugs International Drug Policy Consortium
Statement by the UN expert on the right to health on the protection of people who use drugs during the COVID-19 pandemic Office of the High Commissioner of Human Rights, United Nations
COVID-19 Guidance: Consumption and Treatment Services (CTS) Sites  Ontario Ministry of Health
COVID-19 Guidance for the Health Sector  Ontario Ministry of Health and Ministry of Long-Term Care

 

Professional Policies and Guides

Professional Policies and Guides

Resource Organization
COVID-19: Information for Opioid Agonist Treatment Prescribers and Pharmacists  British Columbia Centre on Substance Use
Opioid Stewardship Under the New CDSA Exemptions (webinar) Canadian Pharmacists Association
Early Guidance for Pharmacists in Managing Opioid Agonist Treatment during the COVID-19 Pandemic Centre for Addiction and Mental Health
Frequently Asked Questions: Subsection 56(1) Class Exemption for Patients, Practitioners and Pharmacists Prescribing and Providing Controlled Substances in Canada during the Coronavirus Pandemic Health Canada
CDSA Exemption and Interpretive Guide for Controlled Substances Health Canada
Clinical guide for the management of people with alcohol dependence during the coronavirus pandemic National Health Service, England
COVID-19: Working with vulnerable people Royal College of Psychiatrists, U.K.
A public health approach to withdrawal management in a pandemic Vancouver Coastal Health
Prescriber Guidelines for Risk Mitigation in the Context of Dual Public Health Emergencies Vancouver Coastal Health

 

Resource Collections

Resource Collections

Resource Organization
COVID-19 Webinars Addictions Foundation of Manitoba
Substance Use and COVID-19 B.C. Centre on Substance Use
COVID-19 National Emergency Response California Bridge
COVID-19 Harm Reduction Resources  Canadian Drug Policy Coalition
COVID-19 Pandemic — National Rapid Guidance Canadian Research Initiative in Substance Misuse
Online resources of support for people with substance use disorders  Canadian Society of Addiction Medicine
Novel Coronavirus (COVID-19) (Information for the public, health professionals and community leaders)  First Nations Health Authority
COVID-19 Resources Foundation for Opioid Response Efforts
Resources for Safer Gambling During COVID-19 Gambling Research Exchange Ontario
Resources for Canadians living with pain during COVID-19 Government of Canada
Wellness Together Canada: Mental Health and Substance Use Support Government of Canada
COVID-19 printable materials, sector resources and webinar recordings Homelessness Services Association of BC
Coronavirus disease (COVID-19): Resources and information International Drug Policy Consortium (IDPC)
Coronavirus Disease (COVID-19) Resources NAADAC : The Association for Addictions Professionals
COVID-19 Harm Reduction COVID-19: Stay Home, Stay Safe New Zealand Drug Foundation
COVID-19 news and resources for people living with pain Pain BC
Synopsis of Key Articles – Coronavirus Disease 2019 (COVID-19) Public Health Ontario
Coronavirus (COVID-19) SAMHSA Resources and Information Substance Abuse and Mental Health Services Administration
COVID-19 Webinars Addictions Foundation of Manitoba
COVID-19 HIV Prevention, Treatment, Care and Support for People Who Use Drugs and People in Prison   United Nations Office on Drugs and Crime

We use cookies to ensure that we give you the best experience possible on our website. 

You can change your cookie settings in your web browser at any time. If you continue without changing your settings, we’ll assume that you are happy to receive cookies from our website. Review our Privacy Notice for more information.